 |
|
FURTHER STUDIES ON THE RELATIONSHIP OF Sf 10-20 LIPOPROTEIN MOLECULES TO ATHEROSCLEROSIS
THOMAS P. LYON, M.D.;
HARDIN B. JONES, Ph.D.;
DEAN M. GRAHAM, B.S.;
JOHN W. GOFMAN, M.D.;
FRANK T. LINDGREN;
A. YANKLEY, M.D.
AMA Arch Intern Med. 1952;89(3):421-427.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
WE HAVE previously presented evidence relating certain lipoprotein molecules of the serum of human beings and experimental animals with the development of atherosclerosis.1 It is the purpose of this report to evaluate a clinical follow-up study which has further amplified this relationship.
The basic premise of this research was that there might be a defect in the molecules which transport fats and cholesterol that could be more intimately related to the pathogenesis of atherosclerosis than are the total analytical levels of the various lipids themselves, e. g., serum cholesterol levels. Since cholesterol, its esters, neutral fat, and phospholipids are all transported in the blood via giant lipoprotein molecules, it was necessary to develop a technique for measuring both the types and the concentration of lipoproteins present in a small sample of blood from an individual patient. The ultracentrifuge has proved highly useful for this purpose. In the ultracentrifuge, under
. . . [Full Text PDF of this Article]
Author Affiliations
BERKELEY, CALIF.
From the Division of Medical Physics, University of California.
Footnotes
This work is supported in part by the United States Atomic Energy Commission and the United States Public Health Service.
Read before the Section on Internal Medicine at the One Hundredth Annual Session of the American Medical Association, Atlantic City, June 13, 1951.
|
